Briacell Therapeutics Corp (BCTX)

$3.08 -0.18 (-5.52%)
Market Cap 24.00M
Revenue (ttm) 0.00
Net Income (ttm) -26.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 178,200
Avg Vol 213,500
Day's Range N/A - N/A
Shares Out 7.25M
Stochastic %K 6%
Beta 1.21
Analysts Strong Buy
Price Target $40.00

Company Profile

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 921 1810
Fax: 604 921 1898
Address:
Bellevue Centre, Suite 300 235 -15th Street, West Vancouver, Canada
JediGreen
JediGreen Jun. 6 at 10:36 AM
$BCTX So they say the global stock market is worth around 100 trillion dollars. So if phase 3 is good wouldn’t you think some of that money might be interested. Short sellers don’t even realize the fire they are playing with and what it could look like if things don’t go there way. Bullish baby.
0 · Reply
JediGreen
JediGreen Jun. 6 at 8:39 AM
$BCTX https://youtube.com/watch?v=BdKFIz-GaME&si=o2vFhbeZpmNINpHR
0 · Reply
JediGreen
JediGreen Jun. 6 at 8:17 AM
$BCTX The big question is for you that don’t know what the federal reserve really is. Should America 🇺🇸 and other countries ever gave a private banking cartel control over are currency’s when we went off the gold standard? Truly is interesting. Tell you the truth i think it was Nixon that did that if I remember right and I’m pretty sure it was unconstitutional that are founding fathers put on paper. 
0 · Reply
JediGreen
JediGreen Jun. 6 at 8:00 AM
$BCTX https://youtube.com/watch?v=2yLrN2W-N2s&si=q431dY7ARqDil1d3
0 · Reply
JediGreen
JediGreen Jun. 6 at 5:06 AM
$BCTX Never seen anything quite like it . Every thing is down. Major Indexes, oil, gold, silver, crypto. F the elites and the new world order. The grait awakening. Globalist will fail. 
0 · Reply
Kings124566
Kings124566 Jun. 5 at 9:52 PM
$BCTX Nooooo!!!!
0 · Reply
TopCharts
TopCharts Jun. 5 at 8:14 PM
$BCTX I would expect another offering later this year whether or not it comes after Ph3 data release is question.
0 · Reply
ZacksResearch
ZacksResearch Jun. 5 at 5:37 PM
$BCTX just raised fresh capital — what does it mean for the next phase? 👀 BriaCell closed a best-efforts offering of 1,449,300 common shares at $3.25 per share, generating approximately $4.7 million in gross proceeds. 💰 The company plans to use the net proceeds for working capital, general corporate purposes, and advancing its business objectives. See what Wall Street expects next 👉 https://www.zacks.com/stock/research/BCTX/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38325&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38325
0 · Reply
2maligators
2maligators Jun. 5 at 4:06 PM
$BCTX How are we gonna stay over $3 if we’re not expecting the big news til later this year? …
0 · Reply
rp6577
rp6577 Jun. 5 at 3:33 PM
$BCTX added
0 · Reply
Latest News on BCTX
BriaCell Therapeutics Announces Closing of Offering

Tue, 02 Jun 2026 16:05:00 -0400 - 3 days ago

BriaCell Therapeutics Announces Closing of Offering

BriaCell Presents Positive Clinical Data at ASCO 2026

Mon, 01 Jun 2026 07:30:00 -0400 - 5 days ago

BriaCell Presents Positive Clinical Data at ASCO 2026

BriaCell Therapeutics Announces Pricing of Offering

Sun, 31 May 2026 19:59:00 -0400 - 5 days ago

BriaCell Therapeutics Announces Pricing of Offering

BriaCell (BCTX) Receives Positive Update from Data Safety Monitoring Board

2026-05-26T14:43:01.000Z - 10 days ago

BriaCell (BCTX) Receives Positive Update from Data Safety Monitoring Board

BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study

2026-05-26T13:05:39.000Z - 10 days ago

BriaCell receives recommendation for DSMB for Phase 3 Bria-ABC study

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Tue, 26 May 2026 07:30:00 -0400 - 11 days ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

BriaCell (BCTX) Unveils Key Clinical Data at ASCO Annual Meeting 2026

2026-05-22T13:27:19.000Z - 14 days ago

BriaCell (BCTX) Unveils Key Clinical Data at ASCO Annual Meeting 2026

BriaCell announces data from Bria-IMT at ASCO 2026

2026-05-22T11:49:02.000Z - 14 days ago

BriaCell announces data from Bria-IMT at ASCO 2026

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

Fri, 22 May 2026 07:30:00 -0400 - 15 days ago

BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

Fri, 15 May 2026 07:30:00 -0400 - 22 days ago

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

BriaCell (BCTX) Completes Manufacturing for New Prostate Cancer Treatment

2026-05-14T15:31:53.000Z - 22 days ago

BriaCell (BCTX) Completes Manufacturing for New Prostate Cancer Treatment

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

Thu, 14 May 2026 07:30:00 -0400 - 23 days ago

BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

BriaCell (BCTX) Expands Clinical Trial Network for Advanced Breast Cancer Treatment

2026-05-13T16:39:28.000Z - 23 days ago

BriaCell (BCTX) Expands Clinical Trial Network for Advanced Breast Cancer Treatment

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

2026-05-13T14:41:55.000Z - 23 days ago

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Wed, 13 May 2026 07:30:00 -0400 - 24 days ago

BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Tue, 12 May 2026 07:30:00 -0400 - 25 days ago

BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Thu, 07 May 2026 07:30:00 -0400 - 4 weeks ago

BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

2026-05-07T04:03:56.000Z - 4 weeks ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

Wed, 06 May 2026 07:30:00 -0400 - 4 weeks ago

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Mon, 27 Apr 2026 07:30:00 -0400 - 5 weeks ago

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

2026-04-21T13:28:43.000Z - 6 weeks ago

BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting

BriaCell presents anti-cancer activity of Bria-OTS

2026-04-21T11:54:23.000Z - 6 weeks ago

BriaCell presents anti-cancer activity of Bria-OTS

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

Tue, 21 Apr 2026 07:30:00 -0400 - 6 weeks ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting

2026-04-20T13:32:04.000Z - 6 weeks ago

BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

2026-04-20T11:41:56.000Z - 6 weeks ago

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Mon, 20 Apr 2026 07:30:00 -0400 - 6 weeks ago

BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

Tue, 31 Mar 2026 16:05:00 -0400 - 2 months ago

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting

2026-03-18T13:30:56.000Z - 2 months ago

BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeting

BriaCell to present four posters at the 2026 AACR

2026-03-18T11:42:55.000Z - 2 months ago

BriaCell to present four posters at the 2026 AACR

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

Wed, 18 Mar 2026 07:30:00 -0400 - 2 months ago

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

Tue, 10 Mar 2026 07:30:00 -0400 - 3 months ago

BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Thu, 05 Mar 2026 16:04:00 -0500 - 3 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

2026-02-18T22:51:30.000Z - 3 months ago

BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

2026-02-18T22:35:25.000Z - 3 months ago

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

Wed, 18 Feb 2026 17:30:00 -0500 - 3 months ago

BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

2026-02-17T12:40:59.000Z - 3 months ago

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

Tue, 17 Feb 2026 07:30:00 -0500 - 3 months ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment

2026-01-28T13:30:56.000Z - 4 months ago

BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment

BriaCell says patient images show regression, resolution of metastsized tumors

2026-01-28T12:40:40.000Z - 4 months ago

BriaCell says patient images show regression, resolution of metastsized tumors

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

Wed, 28 Jan 2026 07:30:00 -0500 - 4 months ago

BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation

BriaCell (BCTX) Reports Promising Phase 2 Survival Data

2026-01-27T13:32:37.000Z - 4 months ago

BriaCell (BCTX) Reports Promising Phase 2 Survival Data

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

2026-01-27T12:41:04.000Z - 4 months ago

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

Tue, 27 Jan 2026 07:30:00 -0500 - 4 months ago

BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

2026-01-19T16:00:45.000Z - 4 months ago

Is the Market Bullish or Bearish on BriaCell Therapeutics Corp?

Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch

2026-01-16T13:58:57.000Z - 5 months ago

Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

Thu, 15 Jan 2026 16:05:00 -0500 - 5 months ago

BriaCell Therapeutics Announces Closing of US$30 million Public Offering

What's Going On With BriaCell Therapeutics Stock Wednesday?

2026-01-14T11:36:30.000Z - 5 months ago

What's Going On With BriaCell Therapeutics Stock Wednesday?

BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering

2026-01-14T11:19:44.000Z - 5 months ago

BriaCell Plunges On Pricing Announcement Of $30Mln Public Offering

BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7%

2026-01-14T10:55:53.000Z - 5 months ago

BriaCell (BCTX) Unveils $30M Public Offering, Stock Dips 9.7%

BriaCell Therapeutics (BCTX) Launches $30M Public Offering

2026-01-14T06:56:44.000Z - 5 months ago

BriaCell Therapeutics (BCTX) Launches $30M Public Offering

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

Jan 13, 2026, 9:00 PM EST - 5 months ago

BriaCell Therapeutics Announces Pricing of $30 million Public Offering

BriaCell Therapeutics trading resumes

2026-01-13T14:41:11.000Z - 5 months ago

BriaCell Therapeutics trading resumes

BriaCell Therapeutics trading halted, volatility trading pause

2026-01-13T14:35:29.000Z - 5 months ago

BriaCell Therapeutics trading halted, volatility trading pause

BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS

2026-01-13T12:35:49.000Z - 5 months ago

BriaCell reports sustained complete resolution of lung metastasis in Bria-OTS

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

Jan 13, 2026, 7:30 AM EST - 5 months ago

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

Dec 18, 2025, 7:30 AM EST - 6 months ago

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

BriaCell presents Phase 2, Phase 3 data on Bria-IMT at SABCS 2025

2025-12-10T12:41:29.000Z - 6 months ago

BriaCell presents Phase 2, Phase 3 data on Bria-IMT at SABCS 2025

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

Dec 10, 2025, 7:30 AM EST - 6 months ago

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

BriaCell announces Phase 3 patient enrollment on track for 1H26 data readout

2025-12-09T12:35:35.000Z - 6 months ago

BriaCell announces Phase 3 patient enrollment on track for 1H26 data readout

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

Dec 9, 2025, 7:30 AM EST - 6 months ago

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

BriaCell to present Phase 2 survival, Phase 3 data at SABCS 2025

2025-12-02T12:36:29.000Z - 6 months ago

BriaCell to present Phase 2 survival, Phase 3 data at SABCS 2025

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

Dec 2, 2025, 7:30 AM EST - 6 months ago

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

Nov 25, 2025, 7:30 AM EST - 6 months ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

BriaCell, Receptor.AI collaborate on AI small molecular cancer therapeutics

2025-11-20T12:40:35.000Z - 7 months ago

BriaCell, Receptor.AI collaborate on AI small molecular cancer therapeutics

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

Nov 20, 2025, 7:30 AM EST - 7 months ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Nov 18, 2025, 7:30 AM EST - 7 months ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

Nov 7, 2025, 7:30 AM EST - 7 months ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

Nov 4, 2025, 7:30 AM EST - 7 months ago

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

Oct 21, 2025, 7:50 AM EDT - 8 months ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

Oct 21, 2025, 7:30 AM EDT - 8 months ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

Oct 20, 2025, 7:30 AM EDT - 8 months ago

BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

Oct 13, 2025, 7:30 AM EDT - 8 months ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

Oct 3, 2025, 7:30 AM EDT - 8 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

Aug 26, 2025, 7:30 AM EDT - 10 months ago

BriaCell's Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

Aug 25, 2025, 7:30 AM EDT - 10 months ago

BriaCell Awarded $2 Million NCI Grant to Advance Bria-PROS+™ in Prostate Cancer

BriaCell Announces Proposed Effective Date of Share Consolidation

Aug 21, 2025, 12:00 PM EDT - 10 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Aug 13, 2025, 7:30 AM EDT - 10 months ago

BriaCell Selected for MSK's 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

Jul 31, 2025, 7:30 AM EDT - 11 months ago

BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

Jul 30, 2025, 7:30 AM EDT - 11 months ago

BriaCell Awarded New Zealand Patent for its Whole Cell Technology

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

Jul 29, 2025, 7:30 AM EDT - 11 months ago

BriaCell's Subsidiary, BriaPro, Files Patent Application for Immuno-Oncology Platform with Novel Multitargeting Agents

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

Jul 25, 2025, 7:30 AM EDT - 11 months ago

BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025

BriaCell Therapeutics Announces Closing of $15 million Public Offering

Jul 16, 2025, 4:05 PM EDT - 11 months ago

BriaCell Therapeutics Announces Closing of $15 million Public Offering

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

Jul 15, 2025, 3:05 PM EDT - 11 months ago

BriaCell Therapeutics Announces Pricing of $15 million Public Offering

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

Jul 15, 2025, 7:30 AM EDT - 11 months ago

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Jul 11, 2025, 7:30 AM EDT - 11 months ago

BriaCell's Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

JediGreen
JediGreen Jun. 6 at 10:36 AM
$BCTX So they say the global stock market is worth around 100 trillion dollars. So if phase 3 is good wouldn’t you think some of that money might be interested. Short sellers don’t even realize the fire they are playing with and what it could look like if things don’t go there way. Bullish baby.
0 · Reply
JediGreen
JediGreen Jun. 6 at 8:39 AM
$BCTX https://youtube.com/watch?v=BdKFIz-GaME&si=o2vFhbeZpmNINpHR
0 · Reply
JediGreen
JediGreen Jun. 6 at 8:17 AM
$BCTX The big question is for you that don’t know what the federal reserve really is. Should America 🇺🇸 and other countries ever gave a private banking cartel control over are currency’s when we went off the gold standard? Truly is interesting. Tell you the truth i think it was Nixon that did that if I remember right and I’m pretty sure it was unconstitutional that are founding fathers put on paper. 
0 · Reply
JediGreen
JediGreen Jun. 6 at 8:00 AM
$BCTX https://youtube.com/watch?v=2yLrN2W-N2s&si=q431dY7ARqDil1d3
0 · Reply
JediGreen
JediGreen Jun. 6 at 5:06 AM
$BCTX Never seen anything quite like it . Every thing is down. Major Indexes, oil, gold, silver, crypto. F the elites and the new world order. The grait awakening. Globalist will fail. 
0 · Reply
Kings124566
Kings124566 Jun. 5 at 9:52 PM
$BCTX Nooooo!!!!
0 · Reply
TopCharts
TopCharts Jun. 5 at 8:14 PM
$BCTX I would expect another offering later this year whether or not it comes after Ph3 data release is question.
0 · Reply
ZacksResearch
ZacksResearch Jun. 5 at 5:37 PM
$BCTX just raised fresh capital — what does it mean for the next phase? 👀 BriaCell closed a best-efforts offering of 1,449,300 common shares at $3.25 per share, generating approximately $4.7 million in gross proceeds. 💰 The company plans to use the net proceeds for working capital, general corporate purposes, and advancing its business objectives. See what Wall Street expects next 👉 https://www.zacks.com/stock/research/BCTX/price-target-stock-forecast?cid=sm-stocktwits-0-price_target-oc-38325&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_38325
0 · Reply
2maligators
2maligators Jun. 5 at 4:06 PM
$BCTX How are we gonna stay over $3 if we’re not expecting the big news til later this year? …
0 · Reply
rp6577
rp6577 Jun. 5 at 3:33 PM
$BCTX added
0 · Reply
Blockybuster
Blockybuster Jun. 5 at 3:08 PM
hold $BCTX and load up BFRI its heavily underpriced at marketcap of 12million while nearing FDA Decision in September this could triple or more even before potential approval.Best Luck
1 · Reply
Ares77manoe
Ares77manoe Jun. 5 at 2:18 PM
$BCTX adding
1 · Reply
Kirubin
Kirubin Jun. 5 at 1:15 PM
$BCTX $2 s here they come!
0 · Reply
shonv
shonv Jun. 4 at 5:39 PM
$BCTX we need ph3 update
4 · Reply
Kings124566
Kings124566 Jun. 4 at 2:34 PM
$BCTX Wouldn’t be surprised if the big boys are dumping the warrants precisely because Retail is buying them.
2 · Reply
supplySHOCK
supplySHOCK Jun. 4 at 10:27 AM
$WNW $ARBK $BCTX $CMCT form
0 · Reply
JediGreen
JediGreen Jun. 4 at 6:41 AM
$BCTX what could briacell therapeutics be revalued at if phase 3 is good - Google Search https://www.google.com/search?q=what+could+briacell+therapeutics+be+revalued+at+if+phase+3+is+good&sa=X&sca_esv=a82350b6429375af&source=lnms&fbs=ADc_l-ZMtfrlQ0SU6L2D0-D344flsprUi5NYvvJVflrdjdmmndzc87yxCU-u2_IZZ9ETkTM_HbA3DoDZGnoXz0Rfyvue0BQgoBLD40wOylysF54ifkKBxD_ZqR729VB49_Xd3vdoAuxo2gSVRmbXhMMCCfqlh26UzktfjQf0kKA6d3NGvs6c9Fyi2YfXghWQqA8nzCD9cjqptq6D8NW8kWHnijiSzPux_cv3d13UkeLuw17_WMCZR7s&aep=1&ntc=1&ved=2ahUKEwjpwLr__OyUAxWonokEHVJXMxwQ2J8OegQIDhAE&mstk=AUtExfD7X6F4W5vGyGILbIWeNKgb_bAOhPre62_4qoNFxw_EVjAMhVA3ofEM7HnDd4hY91uC9-octO_tprIHiIcte7gYpffXHRtDziLOs9l7MpzZ9o7vC2VXign4seX2Bzc9A6LkrVbikyt7UaDX-xrljoTuyB_1ANIiCQ0&csuir=1&udm=50&biw=430&bih=721&dpr=3
0 · Reply
JediGreen
JediGreen Jun. 4 at 6:17 AM
$BCTX
0 · Reply
JediGreen
JediGreen Jun. 4 at 6:17 AM
$BCTX what's the typical market cap for a small pharmaceutical company - Google Search https://www.google.com/search?q=whats+the+tipical+marcat+cap+for+a+small+pharmaceutical+company&sca_esv=a82350b6429375af&source=hp&ei=5hchasHoK67vmLQPh9WYuA0&biw=430&bih=721&oq=&gs_lp=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&sclient=mobile-gws-wiz-hp#lfId=ChxjMe
0 · Reply
rp6577
rp6577 Jun. 3 at 6:15 PM
$BCTX it could get crazy here
0 · Reply
EscapePlan
EscapePlan Jun. 3 at 3:56 PM
$BCTX Well, that's me done. 50,000 after picking 5,000 at 0.9 today and then 15,000 at less than 0.82. Still less than 10% of my portfolio but a huge bet for me.
1 · Reply
EscapePlan
EscapePlan Jun. 3 at 3:51 PM
$BCTX "The share quantity entered for this order is greater than the maximum allowed. Please review your order or contact a Fidelity representative at 1-800-544-6666 for additional information."
0 · Reply